Lux Capital-backed SPAC goes public

Lux Health Tech Acquisition Corp, a blank check company backed by Lux Capital, has raised $300 million for its IPO after pricing its 30 million shares at $10 per share.

Lux Health Tech Acquisition Corp, a blank check company backed by Lux Capital, has raised $300 million for its IPO after pricing its 30 million shares at $10 per share. The stock began trading October 27, 2020 on the NASDAQ under the ticker symbol “LUXAU.” Credit Suisse Securities (USA) LLC is the underwriter.

PRESS RELEASE

NEW YORK–(BUSINESS WIRE)–Lux Health Tech Acquisition Corp. (the “Company”) announced today the pricing of its initial public offering of 30,000,000 units at a price of $10.00 per unit. The units will be listed on the Nasdaq Stock Market, LLC (“Nasdaq”) and will trade under the ticker symbol “LUXAU” beginning on October 27, 2020. Each unit issued in the offering consists of one share of the Company’s Class A common stock and one-third of one warrant, each whole warrant entitling the holder thereof to purchase one share of Class A common stock at an exercise price of $11.50 per share. After the securities comprising the units begin separate trading, the shares of Class A common stock and warrants are expected to be listed on Nasdaq under the symbols “LUXA” and “LUXAW,” respectively. No fractional warrants will be issued upon separation of the units and only whole warrants will trade.

Credit Suisse Securities (USA) LLC is acting as sole book-running manager for the offering and Stifel, Nicolaus & Company, Incorporated is acting as lead manager. The Company has granted the underwriters a 45-day option to purchase up to an additional 4,500,000 units at the initial public offering price to cover over-allotments, if any.

The offering is being made only by means of a prospectus. Copies of the prospectus may be obtained, when available, from Credit Suisse Securities (USA) LLC, Attn: Prospectus Department, 6933 Louis Stephens Drive, Morrisville, North Carolina 27560, United States, Telephone: 1-800-221-1037, Email: usa.prospectus@credit-suisse.com.

A registration statement relating to these securities has been filed with the Securities and Exchange Commission (“SEC”) and became effective on October 26, 2020. This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About Lux Health Tech Acquisition Corp.
Lux Health Tech Acquisition Corp. is a blank check company sponsored by an affiliate of Lux Capital and formed for the purpose of entering into a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses at the intersection of the healthcare and technology industries.